Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana O Hoff

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|March 19, 2020
Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancerCristina E Ueda, Paulo S Duarte, Luciana A de Castroneves, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumorsMaria A Kouvaraki, Suzanne E Shapiro, Nancy D Perrier, et al.
Clinics (Sao Paulo, Brazil)|June 30, 2023
Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Aline Santos Damascena, et al.
Thyroid : Official Journal of the American Thyroid Association|February 16, 2020
Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?Debora L S Danilovic, Luciana A Castroneves, Claudia K Suemoto, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2015
AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomasMiguel F Herrera, Göran Åkerström, Peter Angelos, et al.
CA: a Cancer Journal for Clinicians|May 12, 2026
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-makingLucas Kallas-Silva, Victor Alexandre Dos Santos Valsecchi, Ana O Hoff, et al.
Future Oncology (London, England)|August 15, 2022
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve <i>RET</i>-mutant medullary thyroid cancerLori J Wirth, Marcia S Brose, Rossella Elisei, et al.
Thyroid : Official Journal of the American Thyroid Association|March 10, 2017
Assessment of Depression, Anxiety, Quality of Life, and Coping in Long-Standing Multiple Endocrine Neoplasia Type 2 PatientsKarine C Rodrigues, Rodrigo A Toledo, Flavia L Coutinho, et al.
JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.
Archives of Endocrinology and Metabolism|March 1, 2024
Differentiated thyroid carcinoma: what the nonspecialists needs to knowAna O Hoff, Aline Lauda Freitas Chaves, Thiago Bueno de Oliveira, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|March 19, 2020
Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancerCristina E Ueda, Paulo S Duarte, Luciana A de Castroneves, et al.
Thyroid : Official Journal of the American Thyroid Association|July 21, 2005
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumorsMaria A Kouvaraki, Suzanne E Shapiro, Nancy D Perrier, et al.
Clinics (Sao Paulo, Brazil)|June 30, 2023
Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Aline Santos Damascena, et al.
Thyroid : Official Journal of the American Thyroid Association|February 16, 2020
Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?Debora L S Danilovic, Luciana A Castroneves, Claudia K Suemoto, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2015
AACE/ACE disease state clinical review: pancreatic neuroendocrine incidentalomasMiguel F Herrera, Göran Åkerström, Peter Angelos, et al.
CA: a Cancer Journal for Clinicians|May 12, 2026
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-makingLucas Kallas-Silva, Victor Alexandre Dos Santos Valsecchi, Ana O Hoff, et al.
Future Oncology (London, England)|August 15, 2022
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve <i>RET</i>-mutant medullary thyroid cancerLori J Wirth, Marcia S Brose, Rossella Elisei, et al.
Thyroid : Official Journal of the American Thyroid Association|March 10, 2017
Assessment of Depression, Anxiety, Quality of Life, and Coping in Long-Standing Multiple Endocrine Neoplasia Type 2 PatientsKarine C Rodrigues, Rodrigo A Toledo, Flavia L Coutinho, et al.
JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.
Archives of Endocrinology and Metabolism|March 1, 2024
Differentiated thyroid carcinoma: what the nonspecialists needs to knowAna O Hoff, Aline Lauda Freitas Chaves, Thiago Bueno de Oliveira, et al.
Pageof 8